ArticleOncotarget2016
GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.
Xiao-Rong Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleOncotarget2016
Xiao-Rong Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.